but because the CYDY team lacks experience present
Post# of 148126
Quote:
but because the CYDY team lacks experience presenting information
Amarex is handling that and they do have experience with many drugs they've handled approved. Now there might not be another company that's handled as complex of a submission as our HIV was.
Quote:
nmbr1stckpckr, you must then presume the FDA has done something to make the process more difficult for CYDY, in spite of zero/any specific evidence to the contrary. The totality of the known missteps do not belong to anyone but Nader. - Rubraquercus
In HIV did Nader ask the FDA to do a combo trial? Did he ask them to insist on 700mg then repeatedly request information from a different trial? In COVID-19 he has done nothing to delay it. If he had insisted on 50 patient interims in both trials then there would be delays.